Brooks Laboratorie informs about updates

22 Aug 2022 Evaluate
Brooks Laboratorie has informed that it enclosed update under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements, 2015) regarding approval for Meropenem Injection 500mg per via land 1 gram per vial (the product) from the United States Food & Drug Administration (USFDA).

The above information is a part of company’s filings submitted to BSE.

Brooks Laboratories Share Price

92.25 -0.45 (-0.49%)
24-Dec-2025 10:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1734.80
Dr. Reddys Lab 1263.55
Cipla 1499.00
Zydus Lifesciences 921.15
Lupin 2109.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×